Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11701167 Systems and methods for therapeutic nasal neuromodulation
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Neurent Medical
0
Date Filed
December 3, 2019
0
Date of Patent
July 18, 2023
0
Patent Applicant
Neurent Medical
0
Patent Application Number
16701855
0
Patent Citations
US Patent 7608275 Systems and methods for delivery of a therapeutic agent
0
US Patent 7654997 Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
0
US Patent 7655243 Methods and systems for toxin delivery to the nasal cavity
0
US Patent 7758571 Methods and apparatus for cryo-therapy
0
US Patent 7771409 Devices, systems and methods useable for treating sinusitis
0
US Patent 7803150 Devices, systems and methods useable for treating sinusitis
0
US Patent 8105817 Methods and systems for toxin delivery to the nasal cavity
0
US Patent 8231613 Deflectable sheath catheters
0
US Patent 8372068 Tissue ablation systems
0
US Patent 8382746 Cryogenic ablation system and method
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11701167
0
Patent Primary Examiner
Michael F Peffley
0
CPC Code
A61B 2018/0016
0
A61B 2018/00214
0
A61B 2018/00267
0
A61B 2018/1405
0
A61B 2018/1407
0
A61B 2018/142
0
A61B 2018/1465
0
A61B 2018/1467
0
A61B 2018/00327
0
A61B 17/1688
0
•••
Find more entities like US Patent 11701167 Systems and methods for therapeutic nasal neuromodulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE